The mission of Spectrum, the CTSA-supported independent research center at Stanford, is to transform the academic enterprise to optimally support clinical and translational research and education (CTRE). Spectrum's programs are designed to extend from the earliest phase of basic discovery to final implementation of these discoveries in the population. The ultimate goals of our efforts are to streamline the translation of basic innovations into practical solutions that maintain and improve human health, and to educate the next generation of CTR leaders. In the next five years. Spectrum will leverage institutional strengths to nurture our entrepreneurial researchers to efficiently transfer discoveries from the laboratory to the bedside and into the community. The CTSA will provide critical resources, services and educational opportunities to ensure progress toward this mission.
The specific aims of Spectrum are: 1) Educate the next generation of investigators with the multidisciplinary skills required to conduct cutting- edge clinical and translational research to meet the opportunities and challenges of medicine in the 21st century. Spectrum will facilitate the transformation of medical research training from a narrow focus on discipline-restricted expertise to a more interdisciplinary team approach where trainees become conversant in the language, processes and tools used across the full extent of the translational pipeline (T1-T4). 2) Create an institutional home conducive to efficiently translating the most innovative discoveries made by our basic, translational and clinical scientists into products and processes that directly improve human health and well-being. Spectrum will provide the institutional environment to identify and then support those discoveries that are most ready for translation. 3) Develop and implement CTRE resources and services to accelerate the translation of discoveries into better human health, while simultaneously reducing operating costs. Spectrum will ensure that investigators receive the necessary clinical trial, informatics, statistics, regulatory, ethics and administrative support to maximize their research productivity, and optimize the participation of diverse populations.

Public Health Relevance

The mission of Spectrum, Stanford's CTSA-supported center, is to transform the enterprise to best support discovery, innovation and education in clinical and translational research across the university. Spectrum's programs extend from the earliest phase of basic discovery to final implementation in the population, with an ultimate goal of strengthening healthcare and improving cost efficiencies.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
5UL1TR001085-05
Application #
9268094
Study Section
Special Emphasis Panel (ZAI1-PTM-C (S2))
Program Officer
Talbot, Bernard
Project Start
2013-09-26
Project End
2018-04-30
Budget Start
2017-05-01
Budget End
2018-04-30
Support Year
5
Fiscal Year
2017
Total Cost
$7,613,082
Indirect Cost
$2,760,333
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Mao, Qingqing; Jay, Melissa; Hoffman, Jana L et al. (2018) Multicentre validation of a sepsis prediction algorithm using only vital sign data in the emergency department, general ward and ICU. BMJ Open 8:e017833
Johnston, Emily E; Alvarez, Elysia; Saynina, Olga et al. (2018) Inpatient utilization and disparities: The last year of life of adolescent and young adult oncology patients in California. Cancer 124:1819-1827
Poole, Sarah; Shah, Nigam (2018) Addressing vital sign alarm fatigue using personalized alarm thresholds. Pac Symp Biocomput 23:472-483
Kido, Takashi; Sikora-Wohlfeld, Weronika; Kawashima, Minae et al. (2018) Are minor alleles more likely to be risk alleles? BMC Med Genomics 11:3
Howsmon, Daniel P; Baysal, Nihat; Buckingham, Bruce A et al. (2018) Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas. J Diabetes Sci Technol 12:599-607
Yu, H; MacIsaac, D; Wong, J J et al. (2018) Market share and costs of biologic therapies for inflammatory bowel disease in the USA. Aliment Pharmacol Ther 47:364-370
Gausman, Jewel; Meija Guevara, Ivan; Subramanian, S V et al. (2018) Distributional change of women's adult height in low- and middle-income countries over the past half century: An observational study using cross-sectional survey data. PLoS Med 15:e1002568
Mukherjea, Arnab; Ivey, Susan L; Shariff-Marco, Salma et al. (2018) Overcoming Challenges in Recruitment of South Asians for Health Disparities Research in the USA. J Racial Ethn Health Disparities 5:195-208
Kwong, Allison J; Asrani, Sumeet K (2018) Artificial neural networks and liver transplantation: Are we ready for self-driving cars? Liver Transpl 24:161-163
Chin, Alexander L; Bentley, Jason P; Pollom, Erqi L (2018) The impact of state parity laws on copayments for and adherence to oral endocrine therapy for breast cancer. Cancer :

Showing the most recent 10 out of 406 publications